UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Diagnosing Premotor Multiple System Atrophy: Natural History and Autonomic Testing in an Autopsy Confirmed Cohort

Vichayanrat, Ekawat; Valerio, Fernanda; Koay, Shiwen; De Pablo-Fernandez, Eduardo; Panicker, Jalesh; Morris, Huw; Bhatia, Kailash; ... Iodice, Valeria; + view all (2022) Diagnosing Premotor Multiple System Atrophy: Natural History and Autonomic Testing in an Autopsy Confirmed Cohort. Neurology , 99 (11) e1168-e1177. 10.1212/WNL.0000000000200861. Green open access

[thumbnail of Diagnosing Premotor Multiple System Atrophy_ Natural History and Autonomic Testing in an Autopsy Confirmed Cohort.pdf]
Preview
Text
Diagnosing Premotor Multiple System Atrophy_ Natural History and Autonomic Testing in an Autopsy Confirmed Cohort.pdf - Accepted Version

Download (1MB) | Preview

Abstract

BACKGROUND AND OBJECTIVES: Non-motor features precede motor symptoms in many patients with multiple system atrophy (MSA). However, little is known about differences between the natural history, progression and prognostic factors for survival in MSA subjects with non-motor versus motor presentations. We aimed to compare initial symptoms, disease progression and clinical features at final evaluation and investigate differences in survival and natural history between MSA patients with motor and non-motor presentations. METHODS: Medical records of autopsy-confirmed MSA cases at Queen Square Brain Bank who underwent both clinical examination and cardiovascular autonomic testing were identified. Clinical features, age at onset, gender, time from onset to diagnosis, disease duration, autonomic function tests and plasma noradrenaline levels were evaluated. RESULTS: 47 autopsy-confirmed MSA patients (60+8 years; 28 males) were identified. Time from symptom onset to first autonomic evaluation was 4+2 years and disease duration was 7.7+2.2 years. Fifteen (32%) patients presented with non-motor features including genitourinary dysfunction, orthostatic hypotension or REM sleep behaviour disorder prior to developing motor involvement (median delay 1-6 years). A third (5/15) were initially diagnosed with pure autonomic failure (PAF) before evolving into MSA. All these patients had normal supine plasma noradrenaline levels (332.0+120.3 pg/ml) with no rise on head-up tilt (0.1+0.3 pg/ml).MSA patients with early cardiovascular autonomic dysfunction (within 3 years of symptom onset) had shorter survival compared to those with later onset of cardiovascular autonomic impairment (6.8 years [5.6-7.9] vs 8.5 years [7.9-9.2]; p=0.026).Patients with early urinary catheterisation had shorter survival than those requiring catheterisation later (6.2 years [4.6-7.8] vs 8.5 years [7.6-9.4]; p=0.02). The survival of MSA patients presenting with motor and non-motor symptoms did not differ (p>0.05). DISCUSSION: Almost one-third of MSA patients presented with non-motor features, which could predate motor symptoms by up to 6 years. Cardiovascular autonomic failure and early urinary catheterisation were predictors of poorer outcomes. A normal supine plasma noradrenaline level in patients presenting with PAF phenotype is a possible autonomic biomarker indicating later conversion to MSA.

Type: Article
Title: Diagnosing Premotor Multiple System Atrophy: Natural History and Autonomic Testing in an Autopsy Confirmed Cohort
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1212/WNL.0000000000200861
Publisher version: https://doi.org/10.1212/WNL.0000000000200861
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: autonomic testing, multiple system atrophy, non-motor features, premotor phase multiple system atrophy, pure autonomic failure
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10151971
Downloads since deposit
8Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item